Tvardi Therapeutics, Inc.
TVRD
$3.98
$0.020.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 24.98M | 30.81M | 36.46M | 40.99M | 22.31M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 345.00K | 727.00K | 1.98M | 2.14M | 1.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 25.33M | 31.54M | 38.44M | 43.13M | 23.46M |
|
|
|||||
| Total Current Assets | 25.33M | 31.54M | 38.44M | 43.13M | 23.46M |
| Net Property, Plant & Equipment | 168.00K | 196.00K | 223.00K | 249.00K | 275.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 306.00K | 322.00K | 338.00K | 354.00K | 369.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 17.00K | 17.00K | 17.00K | 17.00K | 3.71M |
| Total Assets | 25.82M | 32.07M | 39.02M | 43.75M | 27.81M |
|
|
|||||
| Total Accounts Payable | 4.62M | 3.22M | 4.08M | 2.43M | 1.69M |
| Total Accrued Expenses | 6.52M | 7.71M | 6.85M | 8.14M | 5.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 120.00K | 116.00K | 113.00K | 109.00K | 106.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.26M | 11.04M | 11.04M | 10.68M | 7.00M |
|
|
|||||
| Total Current Liabilities | 11.26M | 11.04M | 11.04M | 10.68M | 7.00M |
| Long-Term Debt | -- | -- | -- | -- | 35.76M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 54.00K | 85.00K | 115.00K | 145.00K | 174.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.31M | 11.13M | 11.16M | 10.82M | 42.93M |
|
|
|||||
| Common Stock & APIC | 131.76M | 131.39M | 131.03M | 130.59M | 1.19M |
| Retained Earnings | -117.25M | -110.45M | -103.18M | -97.65M | -101.82M |
| Treasury Stock & Other | 1.00K | 8.00K | 7.00K | -13.00K | 2.00K |
| Total Common Equity | 14.51M | 20.95M | 27.87M | 32.93M | -100.63M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 85.50M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 85.50M |
|
|
|||||
| Total Common Equity | 14.51M | 20.95M | 27.87M | 32.93M | -100.63M |
| Total Preferred Equity | -- | -- | -- | -- | 85.50M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 14.51M | 20.95M | 27.87M | 32.93M | -15.12M |
|
|
|||||